Showing results (2631-2640 of 6,166) with videos related to
Sort By:
Pageof 617
Nature Medicine|June 3, 2024
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL studyFranck Morschhauser, Saurabh Dahiya, M Lia Palomba, et al.Nature Medicine|June 1, 2024
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.Nature Medicine|June 1, 2024
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trialFeng Wang, Lin Shen, Weijian Guo, et al.Nature Medicine|June 6, 2024
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trialYi-Bin Chen, Mohamad Mohty, Robert Zeiser, et al.Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.Nature Medicine|July 25, 2024
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trialAnouk E Hiensch, Johanna Depenbusch, Martina E Schmidt, et al.Nature Medicine|July 12, 2024
Hippocampal network activity forecasts epileptic seizuresAnkit N Khambhati, Edward F Chang, Maxime O Baud, et al.Nature Medicine|July 11, 2024
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim resultsMaria Parkhurst, Stephanie L Goff, Frank J Lowery, et al.Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.Nature Medicine|June 14, 2024
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichmentAdam J Widman, Minita Shah, Amanda Frydendahl, et al.Pageof 617